Amplifier TX AB, doing business as Amplifier Therapeutics, is a Sweden-based biopharmaceutical pipeline company within Cambrian Bio. We are focused on developing AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging, including metabolic conditions, cardiovascular disease, kidney disease, and cancer. Our lead asset, ATX-304, is currently in human clinical trials.
| Website | https://www.amplifier-tx.com |
| Employees | 2 (0 on RocketReach) |
| Industry | Biotechnology |
Looking for a particular Amplifier Therapeutics employee's phone or email?
Amplifier Therapeutics Questions
G2Crowd Trusted
300K+
Plugin Users
